| Lung Neuroendocrine Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived133 of 133show fewer |
|---|
| → investigated in trials for | Etoposidesmall molecule 131 trials (50 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 131 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 117 trials (42 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 117 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 74 trials (20 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 74 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 63 trials (23 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 63 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 59 trials (35 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 59 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 53 trials (36 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 53 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 36 trials (11 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 35 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lurbinectedinsmall molecule 29 trials (20 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 23 trials (11 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tarlatamabmonoclonal antibody 23 trials (20 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 21 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 19 trials (14 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 14 trials (6 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 13 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 13 trials (6 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Serplulimabmonoclonal antibody 13 trials (9 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 13 trials (8 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 12 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 12 trials (8 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 12 trials (8 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Amrubicinsmall molecule 11 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rovalpituzumab Tesirineadc 11 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Berzosertibsmall molecule 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin OR Cisplatin 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sugemalimabmonoclonal antibody 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Barasertibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elimusertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganetespibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Guadecitabinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lucitanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegargiminaseother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Picoplatinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vistusertibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | 7-Ethyl-10-Hydroxycamptothecinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abirateronesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Amuvatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aurora A Kinase Inhibitor LY3295668 Erbumine 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabazitaxelsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin/Paclitaxel Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemoimmunotherapy 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chloroquinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dinutuximabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzastaurinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Futibatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganitumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immune Checkpoint Inhibitor 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumab/Nivolumab Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Linsitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lomustinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Margetuximabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Navtemadlinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | PD-L1 Inhibitor 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Platinum Compound 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ponatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Porfimer 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prexasertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rezatapoptsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rilotumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rucaparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tarextumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Teniposidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tretinoinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vandetanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |